|
Trial no.:
|
PACTR202408551861622 |
Date of Registration:
|
12/08/2024 |
|
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
| TRIAL DESCRIPTION |
|
Public title
|
Serum tumour necrosis alpha response to aerobic exercise versus added sugar elimination in obese sedentary females |
| Official scientific title |
Serum tumour necrosis alpha response to aerobic exercise versus added sugar elimination in obese sedentary females |
|
Brief summary describing the background
and objectives of the trial
|
Dietary sugar consumption may increase inflammatory processes in humans due to the synthesis of free fatty acids in the liver. This can trigger inflammatory processes and reactive oxygen species formation. Inactive lifestyles lead to adipose tissue accumulation, immune cell infiltration, and inflammation. Exercise can impede adipose tissue accumulation and promote cardiovascular health by improving blood lipid profiles. Physical activity also has anti-inflammatory effects.
The aim of the trial is to assess the TNF- alpha response to aerobic exercise versus added sugar elimination |
| Type of trial |
RCT |
| Acronym (If the trial has an acronym then please provide) |
|
| Disease(s) or condition(s) being studied |
Nutritional, Metabolic, Endocrine |
| Sub-Disease(s) or condition(s) being studied |
|
| Purpose of the trial |
Treatment: Other |
| Anticipated trial start date |
26/10/2024 |
| Actual trial start date |
|
| Anticipated date of last follow up |
13/02/2025 |
| Actual Last follow-up date |
|
| Anticipated target sample size (number of participants) |
60 |
| Actual target sample size (number of participants) |
|
| Recruitment status |
Not yet recruiting |
| Publication URL |
|
|